How safe are folic acid supplements?

Periconceptual use of folic acid supplements by women is effective in preventing neural tube defects in the fetus. Folic acid supplements also may prevent atherosclerosis and some malignant neoplasms. Nevertheless, safety concerns have delayed recommendations to increase folic acid consumption by the general population. Among the potential safety issues of folic acid supplementation are (1) difficulty identifying cobalamin deficiency, precipitation of neurologic complications of cobalamin deficiency, and lowering of cobalamin levels; (2) folate neurotoxicity; (3) antagonism of drugs that inhibit folate metabolism; (4) reduced zinc absorption; (5) association with malignant neoplasms; (6) hypersensitivity reactions; and (7) increased susceptibility to malaria. The data that suggest that folic acid supplements are unsafe are weak and consist predominantly of case series and reports. Nevertheless, greater difficulty diagnosing cobalamin deficiency due to "masking" of hematologic abnormalities by folic acid is a potential risk. Strict vegetarians need to be informed that they are at risk of cobalamin deficiency. Physicians need to be aware that routine hematologic indexes have a low sensitivity for cobalamin deficiency, especially in patients who are receiving folic acid supplements. Because no high-quality data exclude specific adverse effects, physicians should be vigilant in identifying detrimental effects when patients increase their consumption of folic acid.

[1]  J. Esdaile,et al.  Low-dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis. Results of a multicenter randomized, double-blind, placebo-controlled trial. , 1993, Arthritis and rheumatism.

[2]  M. Weinblatt,et al.  Low dose leucovorin does not interfere with the efficacy of methotrexate in rheumatoid arthritis: an 8 week randomized placebo controlled trial. , 1993, The Journal of rheumatology.

[3]  G. Friedman,et al.  Screening prescription drugs for possible carcinogenicity: eleven to fifteen years of follow-up. , 1989, Cancer research.

[4]  E. Podell,et al.  Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. , 1988, The New England journal of medicine.

[5]  K. Hatch,et al.  Folate deficiency and cervical dysplasia. , 1992, JAMA.

[6]  H. Kirschenbaum,et al.  Folic acid hypersensitivity and fever: a case report. , 1979, American journal of hospital pharmacy.

[7]  B. Cooper,et al.  Vitamin B12—Folate Interrelationships in Megaloblastic Anaemia , 1966, British journal of haematology.

[8]  R. Mattson,et al.  Folate therapy in epilepsy. A controlled study. , 1973, Archives of neurology.

[9]  R. G. Vergel,et al.  Primary prevention of neural tube defects with folic acid supplementation: Cuban experience , 1990, Prenatal diagnosis.

[10]  R. Lovelace,et al.  Relation of abnormal folate metabolism to neuropathy developing during anticonvulsant drug therapy. , 1968, Lancet.

[11]  W. Challener,et al.  Pitfalls in the diagnosis and treatment of pernicious anemia. , 1960, The American journal of the medical sciences.

[12]  N. Wald,et al.  Neural tube defects and serum zinc , 1993 .

[13]  V. Herbert,et al.  Interrelations of vitamin B12 and folic acid metabolism: folic acid clearance studies. , 1962, The Journal of clinical investigation.

[14]  M. Freedman,et al.  Folic Acid Deficiency in the Elderly , 1985, Journal of the American Geriatrics Society.

[15]  G. Omenn,et al.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. , 1995, JAMA.

[16]  R. Carmel,et al.  Physician response to low serum cobalamin levels. , 1986, Archives of internal medicine.

[17]  Hall Be,et al.  Experience with pterolyglutamic (synthetic folic) acid in the treatment of pernicious anemia. , 1947 .

[18]  K. Borch,et al.  Prevalence and incidence of pernicious anemia. An evaluation for gastric screening. , 1984, Scandinavian journal of gastroenterology.

[19]  R. Snaith,et al.  Effects of folic acid on fit-frequency and behaviour in epileptics on anticonvulsants. , 1970, Lancet.

[20]  A. Richens Toxicity of folic acid. , 1971, Lancet.

[21]  R. Allen,et al.  Clinical spectrum and diagnosis of cobalamin deficiency. , 1990, Blood.

[22]  R. Allen,et al.  Diagnosis of cobalamin deficiency I: Usefulness of serum methylmalonic acid and total homocysteine concentrations , 1990, American journal of hematology.

[23]  J. Grigsby,et al.  High Prevalence of Cobalamin Deficiency in Elderly Outpatients , 1992, Journal of the American Geriatrics Society.

[24]  R. P. Thompson,et al.  Are iron-folate supplements harmful? , 1987, The American journal of clinical nutrition.

[25]  P. Mcgeer,et al.  A clinical trial of folic acid in Parkinson's disease. , 1972, Canadian Medical Association journal.

[26]  G. Schiffman,et al.  Impaired Antibody Responses to Pneumococcal Polysaccharide in Elderly Patients with Low Serum Vitamin B12 Levels , 1996, Annals of Internal Medicine.

[27]  E. Reynolds Effects of folic acid on the mental state and fit-frequency of drug-treated epileptic patients. , 1967, Lancet.

[28]  K. Laurence,et al.  Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. , 1981 .

[29]  K. Kosik,et al.  Coma and axonal degeneration in vitamin B12 deficiency. , 1980, Archives of neurology.

[30]  D. Milne,et al.  Effect of oral folic acid supplements on zinc, copper, and iron absorption and excretion. , 1984, The American journal of clinical nutrition.

[31]  Prevention of neural tube defects: Results of the Medical Research Council vitamin study , 1991 .

[32]  J. King,et al.  Folic acid: effect on zinc absorption in humans and in the rat. , 1987, The American journal of clinical nutrition.

[33]  M. Yaron,et al.  The effects of leucovorin (folinic acid) on methotrexate therapy in rheumatoid arthritis patients. , 1988, Arthritis and rheumatism.

[34]  D. Ratner,et al.  Vitamin B12 and folate levels in long-term vegans. , 1990, Israel journal of medical sciences.

[35]  A. Avogaro,et al.  Effeets of folie aeid on phenytoin kineties in healthy subjeets , 1978 .

[36]  J. Olney,et al.  Intrastriatal folic acid mimics the distant but not local brain damaging properties of kainic acid , 1981, Neuroscience Letters.

[37]  M. Malinow Homocyst(e)ine and arterial occlusive diseases , 1994, Journal of internal medicine.

[38]  I. Chanarin Folate and cobalamin. , 1985, Clinics in haematology.

[39]  D. Matthews,et al.  Toxicity of folic acid given in pharmacological doses to healthy volunteers. , 1970, Lancet.

[40]  J. Mulinare,et al.  Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects , 1992 .

[41]  R. Pratt,et al.  A controlled study of folic acid in epilepsy , 1971, Neurology.

[42]  J. Preece,et al.  Influence of folic acid on blood-phenytoin levels. , 1971, Lancet.

[43]  D. Heimburger,et al.  Improvement in bronchial squamous metaplasia in smokers treated with folate and vitamin B12. Report of a preliminary randomized, double-blind intervention trial. , 1988, JAMA.

[44]  L. J. Fischer,et al.  Phenytoin and Folic Acid: Individualized Drug‐Drug Interaction , 1983, Therapeutic drug monitoring.

[45]  J. Brust,et al.  Neurologic Aspects of Cobalamin Deficiency , 1991, Medicine.

[46]  M. Tong,et al.  Supplemental folates in the therapy of Plasmodium falciparum malaria. , 1970, JAMA.

[47]  A. Weinfeld,et al.  Metabolic effects and diagnostic value of small doses of folic acid and B12 in megaloblastic anemias. , 2009, Acta medica Scandinavica.

[48]  R. Carmel,et al.  Unsuspected pernicious anemia in a patient with sickle cell disease receiving routine folate supplementation. , 1987, Archives of internal medicine.

[49]  I. Chanarin The Megaloblastic Anaemias , 1969 .

[50]  G. Block Micronutrients and cancer: time for action? , 1993, Journal of the National Cancer Institute.

[51]  R. G. Strauss,et al.  Folic Acid and Dilantin Antagonism in Pregnancy , 1974, Obstetrics and gynecology.

[52]  J. Heijbel,et al.  Folate treatment of diphenylhydantoin-induced gingival hyperplasia. , 1989, Scandinavian journal of dental research.

[53]  G. Alarcón,et al.  The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis. , 1990, Arthritis and rheumatism.

[54]  R. Vilter,et al.  Hypersensitivity to folic acid. , 1949, Annals of internal medicine.

[55]  D. M. Hoffman,et al.  Exacerbation of rheumatoid arthritis in patients treated with methotrexate after administration of folinic acid. , 1991, Annals of the rheumatic diseases.

[56]  A. D. Welch,et al.  Folic acid in pernicious anemia; failure to prevent neurologic relapse. , 1947, Journal of the American Medical Association.

[57]  G. Alarcón,et al.  Supplementation with Folic Acid during Methotrexate Therapy for Rheumatoid Arthritis: A Double-Blind, Placebo-Controlled Trial , 1994, Annals of Internal Medicine.

[58]  C. Butterworth,et al.  Harmful effect of megadoses of vitamins: electroencephalogram abnormalities and seizures induced by intravenous folate in drug-treated epileptics. , 1975, The American journal of clinical nutrition.

[59]  E. Rimm,et al.  Folate, methionine, and alcohol intake and risk of colorectal adenoma. , 1993, Journal of the National Cancer Institute.

[60]  Davis Re,et al.  Allergy to folic acid. , 1966 .

[61]  H. Hoffman,et al.  Maternal serum folate and zinc concentrations and their relationships to pregnancy outcome. , 1992, The American journal of clinical nutrition.

[62]  H. Schrøder,et al.  Folic acid supplements in vitamin tablets: a determinant of hematological drug tolerance in maintenance therapy of childhood acute lymphoblastic leukemia. , 1986, Pediatric hematology and oncology.

[63]  A. Griffiths,et al.  Diagnosis of cobalamin deficiency. , 1991, Blood.

[64]  S. Kaplan,et al.  The long-term evaluation of folic acid in the treatment of pernicious anemia. , 1950, The Journal of laboratory and clinical medicine.

[65]  K. Hatch,et al.  Zinc concentration in plasma and erythrocytes of subjects receiving folic acid supplementation. , 1988, The American journal of clinical nutrition.

[66]  A. Czeizel,et al.  Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin Supplementation , 1992 .

[67]  J. H. Jandl,et al.  Responses to "physiologic" doses of folic acid in the megaloblastic anemias. , 1960, Archives of internal medicine.

[68]  R. Webster,et al.  Some studies on the convulsant action of folic acid. , 1973, British journal of pharmacology.

[69]  M. Weller,et al.  The reduced unsubstituted pteroate moiety is required for folate toxicity of cultured cerebellar granule neurons. , 1994, Journal of Pharmacology and Experimental Therapeutics.

[70]  R. Minns Folic acid and neural tube defects , 1996, Spinal Cord.

[71]  R. Riezler,et al.  Metabolic evidence that deficiencies of vitamin B-12 (cobalamin), folate, and vitamin B-6 occur commonly in elderly people. , 1993, The American journal of clinical nutrition.

[72]  L. Johnson,et al.  Maternal zinc, iron, folic acid, and protein nutriture and outcome of human pregnancy. , 1984, The American journal of clinical nutrition.

[73]  L. Hellström Lack of toxicity of folic acid given in pharmacological doses to healthy volunteers. , 1971, Lancet.

[74]  W. Bottomley,et al.  The administration of folic acid to institutionalized epileptic adults with phenytoin-induced gingival hyperplasia. A double-blind, randomized, placebo-controlled, parallel study. , 1991, Oral surgery, oral medicine, and oral pathology.

[75]  T. Sheehy Folic acid: lack of toxicity. , 1973, Lancet.

[76]  C. Butterworth,et al.  Folic acid safety and toxicity: a brief review. , 1989, The American journal of clinical nutrition.

[77]  T. Spies,et al.  The use of folic acid in sprue. , 1947, Annals of internal medicine.

[78]  C. Gualtieri,et al.  Toxic effects of water-soluble vitamins. , 2009, Nutrition reviews.

[79]  D. Matthews,et al.  Effect of folic-acid supplement on serum-vitamin-B12 levels in patients on anticonvulsants. , 1969, Lancet.

[80]  O. Olesen,et al.  Subnormal serum folate due to anticonvulsive therapy. A double-blind study of the effect of folic acid treatment in patients with drug-induced subnormal serum folates. , 1970, Archives of neurology.

[81]  P. Duhra Treatment of gastrointestinal symptoms associated with methotrexate therapy for psoriasis. , 1993, Journal of the American Academy of Dermatology.